hydroxyindoleacetic acid has been researched along with brofaromine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, E; Artigas, F; Celada, P; Pérez, J | 1 |
| Baumann, PA; Bernasconi, R; Buech, O; Delini-Stula, A; Felner, AE; Sigg, K; Waldmeier, PC | 1 |
| Baumann, PA; Waldmeier, PC | 1 |
| Feldtrauer, JJ; Paul, E; Stoecklin, K; Waldmeier, PC | 1 |
| Boulton, AA; D'Souza, J; Davis, BA; Durden, DA; Goldbloom, DS; Kennedy, SH | 1 |
| Brown, GM; d'Souza, J; Davis, BA; Ford, CG; Kennedy, SH | 1 |
| Artigas, F; Bel, N | 1 |
| Artigas, F; Bel, N; Casanovas, JM; Romero, L | 1 |
2 trial(s) available for hydroxyindoleacetic acid and brofaromine
| Article | Year |
|---|---|
The effect of the MAO-A selective inhibitor brofaromine on the plasma and urine concentrations of some biogenic amines and their acidic metabolites in bulimia nervosa.
Topics: Biogenic Amines; Bulimia; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Tryptamines; Vanilmandelic Acid | 1993 |
Effects of chronic brofaromine administration on biogenic amines including sulphatoxymelatonin and acid metabolites in patients with bulimia nervosa.
Topics: Adolescent; Adult; Biogenic Amines; Bulimia; Female; Homovanillic Acid; Humans; Hydrogen-Ion Concentration; Hydroxyindoleacetic Acid; Melatonin; Monoamine Oxidase Inhibitors; Piperidines; Tryptamines; Vanilmandelic Acid | 1993 |
6 other study(ies) available for hydroxyindoleacetic acid and brofaromine
| Article | Year |
|---|---|
Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement.
Topics: Adult; Ambulatory Care; Depressive Disorder; Female; Humans; Hydroxyindoleacetic Acid; Male; Middle Aged; Monoamine Oxidase Inhibitors; Phenelzine; Piperidines; Serotonin; Treatment Outcome | 1992 |
Characterization of a new, short-acting and specific inhibitor of type A monoamine oxidase.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Brain Chemistry; Female; Hemodynamics; Hydroxyindoleacetic Acid; Liver; Male; Methoxyhydroxyphenylglycol; Monoamine Oxidase Inhibitors; Piperidines; Rats; Rats, Inbred Strains; Serotonin Antagonists; Synaptosomes; Tranylcypromine | 1983 |
Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.
Topics: Animals; Biogenic Amines; Brain; Brain Chemistry; Clorgyline; Dopamine; Female; Hydroxyindoleacetic Acid; In Vitro Techniques; Monoamine Oxidase Inhibitors; Myocardium; Norepinephrine; Piperidines; Rats; Serotonin; Tryptophan | 1983 |
Reversibility of the interaction of CGP 11305 A with MAO A in vivo.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Clorgyline; Dopamine; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Liver; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Piperidines; Rats; Serotonin; Tetrabenazine | 1983 |
In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Frontal Lobe; Hydroxyindoleacetic Acid; Male; Microdialysis; Monoamine Oxidase Inhibitors; Piperidines; Rats; Rats, Wistar; Serotonin; Time Factors | 1995 |
Adaptative changes of the serotonergic system after antidepressant treatments.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Clomipramine; Clorgyline; Fluvoxamine; Frontal Lobe; Hydroxyindoleacetic Acid; Imipramine; Microdialysis; Monoamine Oxidase Inhibitors; Piperidines; Pyrimidines; Raphe Nuclei; Rats; Serotonin; Stereotaxic Techniques; Tranylcypromine; Tryptophan | 1996 |